PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.64%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.17%
Negative gross profit growth while ADI is at 3.61%. Joel Greenblatt would examine cost competitiveness or demand decline.
-13.26%
Negative EBIT growth while ADI is at 38.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.91%
Negative operating income growth while ADI is at 38.69%. Joel Greenblatt would press for urgent turnaround measures.
-20.48%
Negative net income growth while ADI stands at 64.46%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-19.48%
Negative EPS growth while ADI is at 62.86%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.74%
Negative diluted EPS growth while ADI is at 67.65%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.21%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.19%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.21%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-52.12%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-57.63%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
72.62%
10Y revenue/share CAGR 1.25-1.5x ADI's 60.44%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
16.03%
5Y revenue/share CAGR at 50-75% of ADI's 21.53%. Martin Whitman would worry about a lagging mid-term growth trajectory.
10.46%
3Y revenue/share CAGR at 50-75% of ADI's 13.96%. Martin Whitman would question if the firm lags behind competitor innovations.
89.65%
10Y OCF/share CAGR 1.25-1.5x ADI's 74.11%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
1.26%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
48.44%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
159.95%
Net income/share CAGR above 1.5x ADI's 100.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
17.70%
Below 50% of ADI's 40.86%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
170.91%
3Y net income/share CAGR above 1.5x ADI's 22.69%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
41.87%
10Y equity/share CAGR at 75-90% of ADI's 55.28%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
24.85%
Below 50% of ADI's 65.05%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.50%
Below 50% of ADI's 19.66%. Michael Burry suspects a serious short-term disadvantage in building book value.
1248.38%
10Y dividend/share CAGR above 1.5x ADI's 514.96%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
182.07%
5Y dividend/share CAGR above 1.5x ADI's 85.56%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
99.80%
3Y dividend/share CAGR above 1.5x ADI's 47.95%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
11.88%
AR growth well above ADI's 1.45%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.36%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.12%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.01%
Under 50% of ADI's 1.02%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.09%
We’re deleveraging while ADI stands at 0.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
8.68%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.33%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.